Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
4.800
+0.080 (1.69%)
Jan 31, 2025, 11:54 AM EST - Market open
Humacyte Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
185
Market Cap
617.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 1.57M | 302.00K | 23.91% |
| Dec 31, 2021 | 1.26M | -228.00K | -15.29% |
| Dec 31, 2020 | 1.49M | -4.70M | -75.90% |
| Dec 31, 2019 | 6.19M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 63.17B |
| AbbVie | 55.53B |
| Novartis AG | 51.72B |
| AstraZeneca | 51.21B |
| Thermo Fisher Scientific | 42.88B |
| Abbott Laboratories | 41.95B |
HUMA News
- 10 days ago - Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting - GlobeNewsWire
- 14 days ago - HUMA Deadline: Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
- 14 days ago - DEADLINE TODAY: The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Humacyte, Inc. - Accesswire
- 14 days ago - Humacyte, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - HUMA - PRNewsWire
- 15 days ago - DEADLINE TOMORROW: Humacyte, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 16 days ago - SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte - PRNewsWire
- 16 days ago - The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Humacyte Inc - Accesswire
- 17 days ago - Humacyte, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm - Accesswire